These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 2354565)

  • 21. Usefulness of fractional excretion of sodium as index of cyclosporine nephrotoxicity in renal transplantation.
    Morales JM; Andres A; Alcazar JM; Prieto C; Diaz de Tueste I; Ruilope LM; Rodicio JL
    Transplant Proc; 1988 Jun; 20(3 Suppl 3):691-9. PubMed ID: 3291305
    [No Abstract]   [Full Text] [Related]  

  • 22. Ultrastructural study of cyclosporine-associated arteriolopathy in renal allografts.
    Yamaguchi Y; Teraoka S; Yagisawa T; Takahashi K; Toma H; Ota K
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1517-22. PubMed ID: 2652489
    [No Abstract]   [Full Text] [Related]  

  • 23. The effect of donor age and sex on cyclosporine associated nephrotoxicity.
    Iguro T; Okazaki H; Sato T; Jimbo M; Oguma S
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1554-5. PubMed ID: 2652504
    [No Abstract]   [Full Text] [Related]  

  • 24. Is cyclosporine-associated nephrotoxicity progressive?
    Vanrenterghem Y; Waer M; Roels L; Lerut T; Michielsen P
    Transplant Proc; 1987 Oct; 19(5):4031-2. PubMed ID: 3313992
    [No Abstract]   [Full Text] [Related]  

  • 25. A diagnostic path in ciclosporin nephrotoxicity.
    Segoloni GP; Messina M; Squiccimarro G; Piccoli GB; Triolo G; Vercellone A
    Contrib Nephrol; 1989; 70():94-8. PubMed ID: 2670445
    [No Abstract]   [Full Text] [Related]  

  • 26. Somatic growth and renal function in pediatric renal transplantation with alternate-day steroid immunosuppression using cyclosporine (CsA) in Japan.
    Kawaguchi H; Komatsu Y; Hattori M; Nagata M; Ito K; Takahashi K; Teraoka S; Toma H; Ota K
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1698-700. PubMed ID: 2652556
    [No Abstract]   [Full Text] [Related]  

  • 27. Are serum creatinine levels adequate to identify the onset of chronic cyclosporine A nephrotoxicity?
    Mobb GE; Veitch PS; Bell PR
    Transplant Proc; 1990 Aug; 22(4):1708-10. PubMed ID: 2389439
    [No Abstract]   [Full Text] [Related]  

  • 28. Recurrence of oxalate deposition in a renal transplant during ciclosporin A therapy.
    Drachman R; Dollberg L; Drukker A
    Child Nephrol Urol; 1988-1989; 9(1-2):90-2. PubMed ID: 3075154
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cyclosporine nephrotoxicity: exploration of the risk factors and prognosis of the renal injury.
    Keown PA; Stiller CR; Wallace AC; McKenzie FN; Wall W
    Transplant Proc; 1985 Aug; 17(4 Suppl 1):247-53. PubMed ID: 3895663
    [No Abstract]   [Full Text] [Related]  

  • 30. Prolonged oliguric renal failure related to cyclosporin A in a renal transplant recipient.
    Bear R; Walker F; Lang A
    Am J Nephrol; 1983; 3(5):293-4. PubMed ID: 6356922
    [No Abstract]   [Full Text] [Related]  

  • 31. Chronic cyclosporine nephrotoxicity in renal transplantation: is it the effect of preservation?
    Kumar MS; Samhan M; John P; al-Adnani MS; Abouna GM
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1552-3. PubMed ID: 2652503
    [No Abstract]   [Full Text] [Related]  

  • 32. [Pneumocystis carinii pneumonia in renal transplant recipients treated with cyclosporin].
    Kim CJ; Pak K; Wakabayashi Y; Ishida A; Arai Y; Konishi T; Kounami T; Tomoyoshi T; Sako H; Okino K
    Hinyokika Kiyo; 1989 Apr; 35(4):653-9. PubMed ID: 2544088
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Is chronic nephrotoxicity of cyclosporine avoided by the triple drug regimen?
    Hiesse C; Gardin JP; Lantz O; Cantarovich M; Bensadoun H; Benoit G; Bellamy J; Paillard M; Charpentier B; Fries D
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1534-6. PubMed ID: 2652495
    [No Abstract]   [Full Text] [Related]  

  • 34. Cyclosporine, azathioprine, and prednisone as treatment for cyclosporine-induced nephrotoxicity in renal transplant recipients.
    Lorber MI; Flechner SM; Van Buren CT; Kerman RH; Kahan BD
    Transplant Proc; 1985 Aug; 17(4 Suppl 1):282-5. PubMed ID: 3895668
    [No Abstract]   [Full Text] [Related]  

  • 35. Effects on renal function of combined treatment with trimethoprim and cyclosporine A in kidney transplant patients.
    Berg KJ; Nordby G; Rootwelt K; Djøseland O; Fauchald P; Mehl A; Narverud J; Talseth T
    Transplant Proc; 1988 Jun; 20(3):413-5. PubMed ID: 3289171
    [No Abstract]   [Full Text] [Related]  

  • 36. The role of ultrasound in the diagnosis of cyclosporine toxicity in renal transplantation.
    Bergren CT; Toledo-Pereyra LH; Craig BM; Fawcett KJ
    Bol Asoc Med P R; 1986 Feb; 78(2):50-4. PubMed ID: 3518734
    [No Abstract]   [Full Text] [Related]  

  • 37. Cyclosporine-associated hemolytic uremic syndrome in four renal allograft recipients: resolution without specific therapy.
    Buturović J; Kandus A; Malovrh M; Bren A; Drinovec J
    Transplant Proc; 1990 Aug; 22(4):1726-7. PubMed ID: 2389443
    [No Abstract]   [Full Text] [Related]  

  • 38. The effect of cyclosporine on the early postoperative function of allografted kidneys with warm ischemic damage.
    Ohshima S; Fujita T; Asano H; Ono Y
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2081-4. PubMed ID: 3547911
    [No Abstract]   [Full Text] [Related]  

  • 39. The nephrotoxic effects of cyclosporine metabolites.
    Leunissen KM; Beuman GH; Bosman FT; van Hooff JP
    Transplant Proc; 1988 Jun; 20(3 Suppl 3):738-9. PubMed ID: 3291310
    [No Abstract]   [Full Text] [Related]  

  • 40. The case against conversion to azathioprine in cyclosporine-treated renal recipients.
    Flechner SM; Lorber M; Van Buren C; Kerman R; Kahan BD
    Transplant Proc; 1985 Aug; 17(4 Suppl 1):276-81. PubMed ID: 3895667
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.